Literature DB >> 17504241

The RANTES -403G>A promoter polymorphism in Korean men: association with serum RANTES concentration and coronary artery disease.

Yangsoo Jang1, Jey Sook Chae, Yae Jung Hyun, Soo Jeong Koh, Ji Young Kim, Min Ji Ko, Se-Joong Rim, Hyun-Joon Shin, Jose M Ordovas, Jong Ho Lee.   

Abstract

In the present study we investigated the association of the RANTES (regulated upon activation, normal T-cell expressed and secreted) -28C>G and -403G>A promoter polymorphisms with the concentration of serum RANTES and CAD (coronary artery disease) in Korean men. We included 553 male CAD patients with (n=176) or without (n=377) Type 2 diabetes, aged 40-65 years with previous myocardial infarction ( approximately 50%) or angiographically confirmed CAD ( approximately 50%), and 416 aged-matched healthy male controls. The main outcome measures were the OR (odds ratio) of CAD risk and the serum RANTES concentration evaluated by sandwich ELISA. Although the RANTES -28C>G genotype had no significant association with CAD risk, the presence of the minor allele of the RANTES -403G>A single nucleotide polymorphism was associated with a lower risk of CAD {OR 0.70 [95% CI (confidence interval) 0.54-0.92], P=0.011} after adjusting for age, BMI (body mass index), cigarette smoking and alcohol consumption. Serum RANTES concentrations were significantly associated with the -403G>A genotype in controls (G/G: 44.7+/-3.3 ng/ml, G/A: 36.5+/-2.0 ng/ml, A/A: 28.7+/-2.5 ng/ml; P<0.001), non-diabetic CAD patients (G/G: 50.9+/-3.0 ng/ml, G/A: 42.2+/-2.6 ng/ml, A/A: 41.3+/-4.4 ng/ml; P<0.05) and diabetic CAD patients (G/G: 58.5+/-3.5 ng/ml, G/A: 49.6+/-4.1 ng/ml, A/A: 42.2+/-4.3 ng/ml; P<0.05); however, such associations were not observed in the subgroup of CAD patients taking lipid-lowering medication. Moreover, serum RANTES was positively correlated with C-reactive protein (r=0.289, P<0.001) and platelet counts (r=0.253, P<0.001). The results of the present study demonstrate that the RANTES -403A allele is associated with lower serum RANTES concentrations and consequently with reduced CAD risk.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17504241     DOI: 10.1042/CS20070014

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  16 in total

1.  Association of circulating levels of RANTES and -403G/A promoter polymorphism to acute heart failure after STEMI and to cardiogenic shock.

Authors:  Jolana Lipkova; Jiri Parenica; Kamil Duris; Katerina Helanova; Josef Tomandl; Lenka Kubkova; Anna Vasku; Monika Goldbergova Pavkova
Journal:  Clin Exp Med       Date:  2014-06-17       Impact factor: 3.984

Review 2.  Chemokine receptor CCR5: from AIDS to atherosclerosis.

Authors:  K L Jones; J J Maguire; A P Davenport
Journal:  Br J Pharmacol       Date:  2011-04       Impact factor: 8.739

3.  Polymorphisms of RANTES and IL-4 genes in cerebral infarction.

Authors:  Jae-Young Um; Hyung-Min Kim
Journal:  J Mol Neurosci       Date:  2008-08-12       Impact factor: 3.444

Review 4.  Molecular genetics of atherosclerosis.

Authors:  Himadri Roy; Shalini Bhardwaj; Seppo Yla-Herttuala
Journal:  Hum Genet       Date:  2009-03-20       Impact factor: 4.132

5.  Chemokines CCL3/MIP1α, CCL5/RANTES and CCL18/PARC are independent risk predictors of short-term mortality in patients with acute coronary syndromes.

Authors:  Saskia C A de Jager; Brenda W C Bongaerts; Michael Weber; Adriaan O Kraaijeveld; Mat Rousch; Stefanie Dimmeler; Marja P van Dieijen-Visser; Kitty B J M Cleutjens; Patty J Nelemans; Theo J C van Berkel; Erik A L Biessen
Journal:  PLoS One       Date:  2012-09-21       Impact factor: 3.240

6.  A meta-analysis of the association between the CC chemokine ligand 5 (CCL5) -403 G>A gene polymorphism and tuberculosis susceptibility.

Authors:  M Y Areeshi; Raju K Mandal; Aditya K Panda; Shafiul Haque
Journal:  PLoS One       Date:  2013-08-28       Impact factor: 3.240

7.  Analysis of inflammation- and atherosclerosis-related gene polymorphisms in branch retinal vein occlusion.

Authors:  Iris Steinbrugger; Anton Haas; Richard Maier; Wilfried Renner; Monika Mayer; Christoph Werner; Andreas Wedrich; Yosuf El-Shabrawi; Otto Schmut; Martin Weger
Journal:  Mol Vis       Date:  2009-03-27       Impact factor: 2.367

8.  Personalized medicine in coronary artery disease: insights from genomic research.

Authors:  Sang-Hak Lee; Dong-Jik Shin; Yangsoo Jang
Journal:  Korean Circ J       Date:  2009-04-28       Impact factor: 3.243

9.  RANTES gene G-403A polymorphism and coronary artery disease: a meta analysis of observational studies.

Authors:  Jun Liu; Yan-Jun Jia; Xiao-Lin Li; Rui-Xa Xu; Cheng-Gang Zhu; Yuan-Lin Guo; Na-Qiong Wu; Jian-Jun Li
Journal:  PLoS One       Date:  2012-10-10       Impact factor: 3.240

10.  The CCR5 chemokine receptor mediates vasoconstriction and stimulates intimal hyperplasia in human vessels in vitro.

Authors:  Janet J Maguire; Katie L Jones; Rhoda E Kuc; Murray C H Clarke; Martin R Bennett; Anthony P Davenport
Journal:  Cardiovasc Res       Date:  2013-12-09       Impact factor: 10.787

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.